We are live on ! Find out more
MGP

M&G plc Portfolio holdings

AUM $19.4B
1-Year Est. Return 16.7%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+16.7%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
Cap. Flow
+$1.01M
Cap. Flow %
0.01%
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43

Top Buys

1
AZN icon
AstraZeneca
AZN
+$811M
2
MSFT icon
Microsoft
MSFT
+$183M
3
INTU icon
Intuit
INTU
+$152M
4
AVGO icon
Broadcom
AVGO
+$130M
5
MICC
The Magnum Ice Cream Company N.V.
MICC
+$102M

Top Sells

1
LRCX icon
Lam Research
LRCX
+$190M
2
ELV icon
Elevance Health
ELV
+$109M
3
CME icon
CME Group
CME
+$92.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$79.9M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$67.8M

Sector Composition

1 Technology 20.57%
2 Healthcare 16.38%
3 Consumer Discretionary 15.42%
4 Financials 11.36%
5 Communication Services 6.31%

No holdings matched the selected filter criteria.

12 13 14 15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return

M&G plc's Q1 2026 Portfolio in Review

As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
  • M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
  • M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
  • M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
  • M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
  • M&G plc opened 51 new positions and closed 43 in Q1 2026.
  • M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.

Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.